Hennion & Walsh Asset Management Inc. Raises Stock Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Hennion & Walsh Asset Management Inc. grew its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.7% in the 3rd quarter, HoldingsChannel reports. The institutional investor owned 12,330 shares of the medical equipment provider’s stock after purchasing an additional 3,565 shares during the period. Hennion & Walsh Asset Management Inc.’s holdings in Intuitive Surgical were worth $6,044,000 as of its most recent SEC filing.

A number of other hedge funds have also recently modified their holdings of ISRG. International Assets Investment Management LLC grew its holdings in shares of Intuitive Surgical by 49,383.6% during the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the last quarter. Capital Research Global Investors purchased a new position in Intuitive Surgical during the 1st quarter worth approximately $374,390,000. Vanguard Group Inc. increased its position in Intuitive Surgical by 1.6% during the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock worth $12,319,358,000 after buying an additional 493,126 shares during the period. BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in Intuitive Surgical by 51.2% in the first quarter. BNP PARIBAS ASSET MANAGEMENT Holding S.A. now owns 893,341 shares of the medical equipment provider’s stock valued at $356,524,000 after buying an additional 302,382 shares during the last quarter. Finally, Strategic Financial Concepts LLC lifted its stake in Intuitive Surgical by 40,221.4% in the second quarter. Strategic Financial Concepts LLC now owns 266,121 shares of the medical equipment provider’s stock valued at $1,184,000 after buying an additional 265,461 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Intuitive Surgical Price Performance

Shares of NASDAQ:ISRG opened at $512.58 on Thursday. The firm has a market capitalization of $181.81 billion, a price-to-earnings ratio of 92.52, a price-to-earnings-growth ratio of 5.40 and a beta of 1.39. The business’s 50 day simple moving average is $486.71 and its 200-day simple moving average is $440.96. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $523.34.

Insiders Place Their Bets

In other news, EVP Brian Edward Miller sold 2,553 shares of the firm’s stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. In related news, insider Mark Brosius sold 2,115 shares of Intuitive Surgical stock in a transaction that occurred on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total transaction of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares in the company, valued at $145,113.45. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares in the company, valued at approximately $3,638,990. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 51,455 shares of company stock worth $24,911,155. 0.90% of the stock is owned by corporate insiders.

Analysts Set New Price Targets

A number of equities analysts have recently commented on ISRG shares. Evercore ISI reaffirmed a “cautious” rating on shares of Intuitive Surgical in a report on Friday, October 18th. Piper Sandler restated an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Wells Fargo & Company increased their target price on shares of Intuitive Surgical from $466.00 to $549.00 and gave the stock an “overweight” rating in a research note on Friday, October 18th. Barclays raised their price target on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a report on Thursday, July 18th. Finally, Citigroup increased their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. One research analyst has rated the stock with a sell rating, five have issued a hold rating and fourteen have given a buy rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.